Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial
Source: European Heart Journal - Category: Cardiology Source Type: research
More News: Cardiology | Chronic Kidney Disease | Dapagliflozin | Forxiga | Heart | Urology & Nephrology